M. Aljaafari, M. Alhosani, A. Abushelaibi, K. Lai, S. Lim
{"title":"Essential Oils: Partnering with Antibiotics","authors":"M. Aljaafari, M. Alhosani, A. Abushelaibi, K. Lai, S. Lim","doi":"10.5772/INTECHOPEN.86575","DOIUrl":null,"url":null,"abstract":"Essential oils (EO) are volatile, non-lipid-based oils produced as a plant defense mechanism. Studies from our group have validated the potential usefulness of EOs to synergistically and additively work with antibiotics. In this book chapter, we aim to outline some background on the EOs and their uses and applications, to discuss the different mechanisms of action in partnering with antibiotics, and, finally, to explore their potential use against multidrug-resistant bacteria. Applications of EO in therapy will enable the revival of previously sidelined antibiotics and enhance the development of new drug regimens to better mitigate what may be the biggest health challenge by year 2050.","PeriodicalId":183791,"journal":{"name":"Essential Oils - Oils of Nature","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Essential Oils - Oils of Nature","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.86575","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Essential oils (EO) are volatile, non-lipid-based oils produced as a plant defense mechanism. Studies from our group have validated the potential usefulness of EOs to synergistically and additively work with antibiotics. In this book chapter, we aim to outline some background on the EOs and their uses and applications, to discuss the different mechanisms of action in partnering with antibiotics, and, finally, to explore their potential use against multidrug-resistant bacteria. Applications of EO in therapy will enable the revival of previously sidelined antibiotics and enhance the development of new drug regimens to better mitigate what may be the biggest health challenge by year 2050.